Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Surveys and Questionnaires × Myeloid × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 48 Gastrointestinal 40 Genitourinary 31 Head & Neck 23 Tumor-Agnostic 12 Lymphoid 12 Gynecologic 12 Thoracic 11 Other hematologic neoplasm 11 CNS 11 Sarcoma 6 Plasma cell 5 Dermatologic 5 Endocrine 4 Other solid neoplasm 3 Other 3 NET 2 Other neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 60 fludarabine 58 Azacitidine 57 venetoclax 55 fludarabine phosphate 45 Whole-Body Irradiation 37 Specimen Handling 37 ruxolitinib 32 Tacrolimus 32 Mycophenolic Acid 32 Cytarabine 31 Melphalan 30 Biopsy 29 Decitabine 28 Busulfan 28 Stem Cell Transplantation 24 Injections 20 Granulocyte Colony-Stimulating Factor 19 asciminib 18 Thiotepa 17 Peripheral Blood Stem Cell Transplantation 16 Methotrexate 16 Filgrastim 16 decitabine and cedazuridine drug combination 15 nilotinib 14 Sirolimus 12 Mesna 12 Imatinib Mesylate 12 X-Rays 11 Rituximab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04378855 2025-09-23

PROPHECY

Gruppo Italiano Malattie EMatologiche dell'Adulto

Active not recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡